Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 15, 2023
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
Bill Sutherland Reiterated (AMED) at Strong Buy and Held Target at $115 on, Mar 14th, 2023
Bill Sutherland of Benchmark, Reiterated "Amedisys, Inc." (AMED) at Strong Buy and Held Target at $115 on, Mar 14th, 2023.
Bill has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 2 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Valiquette of "Barclays" Initiated at Hold and Held Target at $93 on, Monday, March 13th, 2023
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
These are the ratings of the 4 analyists that currently disagree with Bill
- Jonathan Yong of "Credit Suisse" Reiterated at Buy and Held Target at $115 on, Monday, February 27th, 2023
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $111 on, Tuesday, February 21st, 2023
- Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023
- Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
